Notice of Shareholder meeting received today - 4/2/13
Dear Shareholder, March 22, 2013
I’m very pleased and excited to address you for the first time since the launching of the pilot
production program for Monster Silk™ and the laboratory development of “Big Red,” a new
form of recombinant spider silk. The pace of our development from a small genetic
engineering company with bold ideas, toward a larger commercial vision, has been
accelerating in this early part of 2013.
Our goal is to further build on that growth and to accelerate our commercial and corporate
development in the second, third and fourth quarters. Our goals have always been
ambitious, but as a shareholder you already know that. What I can tell you today is that as
we have achieved our milestones over the past nine months, our goals have become even
more ambitious. We are currently on track to make 2013 what I believe will be the best year
in the Company’s history. Indeed, we intend to make history with the commercial
development of recombinant spider silk based fibers and textiles.
We are planning on holding a shareholder conference call in the next few weeks, to discuss
our significant progress and to lay out our plan for growth. We will issue a press release
with information on how to join the conference call as soon as the schedule is set.
If you have access to email, the Company would like to add your name to our shareholder
email list. This list will allow the Company to communicate more effectively with you and
our shareholder community. You can subscribe by sending an email containing the words
“shareholder, add me to the list” to the following email address:
Shareholder@KraigLabs.com
We will be sending periodic updates, notices and important press releases to our
shareholders via the shareholder email list.
Thank you for your support of Kraig Biocraft Laboratories, a company which has become
the world leader in recombinant spider silk technologies. We intend to grow larger and
expand that lead in the coming months.
Yours Truly,
Kim Thompson
CEO
NOTICE OF MEETING OF SHAREHOLDERS
TO BE HELD ON APRIL 16, 2013
To the Shareholders of Kraig Biocraft Laboratories, Inc.:
You are invited to attend the Meeting of Shareholders of Kraig Biocraft Laboratories, Inc., a Wyoming
corporation (the “Company”), to be held at the Radisson Hotel, 111 North Grand Ave, in the Michigan 3 Room,
Lansing, Michigan 48933 on April 16, 2013, at 10:00 a.m. local time, for the following purposes:
1. To approve the amendment of the Articles of Incorporation of the Company with the purpose to: (a) allow for
electronic and website based notice of meetings and corporate actions to the greatest extent allowed by law, (b)
allow any action by the Company’s shareholders, in lieu of a meeting, by written consent of the holders of
outstanding shares having not less than the minimum number of votes that would be required to authorize or
take the action at a meeting at which all shares entitled to vote on the action were present and voted, and (c)
authorize the board of directors to classify or reclassify any unissued shares and designate the voting powers
and other rights and privileges of such unissued shares by:
- Adding a new Article 9 to read as follows: “Article 9. Any public notice or notice to the shareholders,
including notice of meetings of the shareholders and notices which are permitted or required by law to
shareholders, may be made by publication on the Company’s website, or by other electronic means, to the
extent that such means of publication are allowed by applicable law.”
- Adding a new Article 10 to read as follows: “Article 10. Any action permitted to be taken at a
shareholders' meeting may be taken without a meeting, and without prior notice, if consents in writing
setting forth the action so taken are signed by the holders of outstanding shares having not less than the
minimum number of votes that would be required to authorize or take the action at a meeting at which all
shares entitled to vote on the action were present and voted.”
- Adding a new Article 11 to read as follows: “Article 11. The Board of Directors is expressly authorized at
any time, and from time to time, to (x) classify any unissued shares in one or more classes or in one or
more series within a class, (y) reclassify any unissued shares of any class into one (1) or more classes or
into one (1) or more series within one (1) or more classes, or (z) reclassify any unissued shares of any
series of any class into one (1) or more classes or into one (1) or more series within a class; with such
voting powers and such designations, preferences and relative, participating, optional or other special
rights, and qualifications, limitations or restrictions thereof, as shall be stated and expressed in the
resolution or resolutions providing for the issue thereof adopted by the Board of Directors, and as are not
stated and expressed in these Articles of Incorporation, or any amendment thereto.”
2. To transact such other matters as may properly come before the meeting or any adjournment thereof.
Only shareholders of record at the close of business on March 18, 2013 are entitled to notice of, and to vote at,
the meeting.
Reasons for the Amendments: To reduce the cost and streamline the logistics involved in calling shareholdermeetings and providing notice to shareholders to the greatest extent allowed by law and to reduce the time it takes to
obtain shareholder or other corporate approval or take action which would otherwise require a calling of a shareholder
meeting, by authorizing written shareholder consent without a meeting to the extent allowed by law and to allow
greater authority for the Board of Directors in determining the rights of unissued classes of stock without the necessity
of further amending the Articles of Incorporation.
Our board of directors has unanimously approved each of the foregoing actions and deemed them to be in the
best interest of the Company. If approved by the shareholders at the Meeting of Shareholders, each action will become
effective as soon as practicable. However, consummation of any of the foregoing actions may be abandoned or
deferred for a reasonable time, by action of the Company’s board of directors at any time, whether before or after its
approval, if the board of directors determines for any reason, in its sole judgment and discretion, that the
consummation of such action would no longer be in the best interests of the shareholders or that the deferral thereof is
advisable.
By Order of the Board of Directors, March 22, 2013
News 
Market Data 
Discover 
